Efficacy Outcomes of Fecal Microbiota, Live-jslm in Preventing Recurrent Clostridioides difficile Infection from Seven Clinical Studies

Abstract Clostridioides difficile infection (CDI) is one of the most common healthcare-associated infections in the US, and recurrence remains a major clinical challenge, as standard-of-care antibiotics fail to prevent recurrence in up to one-third of cases. Fecal microbiota, live-jslm (RBL) is the...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Teena Chopra, Daniel Van Handel, Brian Baggott, Robert Orenstein, Kelly Reveles, Beth Guthmueller, Shivam Srivastava, Sahil Khanna
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	Adis, Springer Healthcare 2026-06-01
श्रृंखला:	Infectious Diseases and Therapy
विषय:	CDI Clostridioides difficile Fecal microbiota, Live-jslm (RBL) Microbiota-based therapy rCDI Efficacy
ऑनलाइन पहुंच:	https://doi.org/10.1007/s40121-026-01374-9
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!